Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahendra Pal

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Clinical Genitourinary Cancer|April 10, 2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors SurveyGagan Prakash, Amandeep Arora, Marco Bandini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2025
Online Adaptive Radiation Therapy for Bladder Preservation: Transitioning to HypofractionationAnuradha Krishnan, Priyamvada Maitre, Sheetal Kashid, et al.
Urologic Oncology|July 28, 2023
Surgical templates for inguinal lymph node dissection in cN0 penile cancer: A comparative studyGanesh K Bakshi, Mahendra Pal, Deep Kumar Jain, et al.
Mikrochimica Acta|October 6, 2021
Au@Zr-based metal-organic framework composite as an immunosensing platform for determination of hepatitis B virus surface antigenVivek K Bajpai, Yuvraj Haldorai, Imran Khan, et al.
Psycho-Oncology|September 8, 2022
Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic - A cross-sectional studyAbhinav Thaduri, Pankaj K Garg, Manu Malhotra, et al.
BMJ Open|March 2, 2020
Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)Vedang Murthy, Indranil Mallick, Abhilash Gavarraju, et al.
Nuclear Medicine Communications|September 14, 2023
Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?Suchismita Ghosh, Archi Agrawal, Venkatesh Rangarajan, et al.
Ecancermedicalscience|April 28, 2023
Management of testicular tumours in patients with undescended testes- a challenging but rewarding task: experience from a tertiary care cancer centre in IndiaArnav Tongaonkar, Vijai Simha, Nandini Menon, et al.
Nuclear Medicine Communications|November 8, 2022
Bone metastases in prostate cancer - Gallium-68-labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography - the better tracer?Archi Agrawal, Aravintho Natarajan, Sneha Mithun, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2024
Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of ProstateManeesh Singh, Priyamvada Maitre, Anuradha Krishnan, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Clinical Genitourinary Cancer|April 10, 2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors SurveyGagan Prakash, Amandeep Arora, Marco Bandini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2025
Online Adaptive Radiation Therapy for Bladder Preservation: Transitioning to HypofractionationAnuradha Krishnan, Priyamvada Maitre, Sheetal Kashid, et al.
Urologic Oncology|July 28, 2023
Surgical templates for inguinal lymph node dissection in cN0 penile cancer: A comparative studyGanesh K Bakshi, Mahendra Pal, Deep Kumar Jain, et al.
Mikrochimica Acta|October 6, 2021
Au@Zr-based metal-organic framework composite as an immunosensing platform for determination of hepatitis B virus surface antigenVivek K Bajpai, Yuvraj Haldorai, Imran Khan, et al.
Psycho-Oncology|September 8, 2022
Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic - A cross-sectional studyAbhinav Thaduri, Pankaj K Garg, Manu Malhotra, et al.
BMJ Open|March 2, 2020
Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)Vedang Murthy, Indranil Mallick, Abhilash Gavarraju, et al.
Nuclear Medicine Communications|September 14, 2023
Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?Suchismita Ghosh, Archi Agrawal, Venkatesh Rangarajan, et al.
Ecancermedicalscience|April 28, 2023
Management of testicular tumours in patients with undescended testes- a challenging but rewarding task: experience from a tertiary care cancer centre in IndiaArnav Tongaonkar, Vijai Simha, Nandini Menon, et al.
Nuclear Medicine Communications|November 8, 2022
Bone metastases in prostate cancer - Gallium-68-labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography - the better tracer?Archi Agrawal, Aravintho Natarajan, Sneha Mithun, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2024
Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of ProstateManeesh Singh, Priyamvada Maitre, Anuradha Krishnan, et al.
Pageof 13